Pure Global

BlastGen - In vitro fertilization culture medium - ARTG 402911

Access comprehensive regulatory information for BlastGen - In vitro fertilization culture medium in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class III is registered under ARTG number 402911 and sponsored by Origio Australasia Pty Ltd, manufactured by Origio A/S in Denmark. The device registration started on January 23, 2023.

This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.

Free Database
Powered by Pure Global AI
TGA ARTG Official Data
Class III
ARTG 402911
Class III
BlastGen - In vitro fertilization culture medium
ARTG ID: 402911
Good Name: Origio Australasia Pty Ltd - BlastGen - In vitro fertilization culture medium
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Intended Purpose

BlastGen is for the culture of 4-8 cell stage human embryos to the blastocyst stage. BlastGen may also be used for embryo transfer.

Device Classification
Risk Class
Class III
Product Type
Single Device Product
ARTG Category
General
Registration Information
ARTG ID
402911
Start Date
January 23, 2023
Effective Date
January 23, 2023
Manufacturer
Country
Denmark
Address
Knardrupvej 2, Malov, DK-2760